T1	tradename 111 117	MEGACE
T2	tradename 182 188	MEGACE
T3	tradename 194 200	MEGACE
T4	activeingredient 205 223	megestrol acetate,
T5	routeofadministration 229 233	Oral
T6	fdaapprovaldate 268 272	1993
T7	tradename 344 344	
T8	routeofadministration 348 352	oral
T9	chemoclass 369 378	progestin
T10	indication 409 428	anorexia, cachexia,
T11	indication 435 470	unexplained significant weight loss
T12	tradename 648 654	Megace
T13	routeofadministration 658 662	oral
T14	dose 677 683	625 mg
T15	frequency 683 687	/day
T16	frequency 693 697	/day
T17	frequency 714 720	daily)
T18	routeofadministration 823 823	
T19	activeingredient 856 873	megestrol acetate
T20	activeingredient 992 1009	megestrol acetate
T21	activeingredient 1461 1479	megestrol acetate.
T22	activeingredient 1607 1624	megestrol acetate
T23	activeingredient 1920 1937	megestrol acetate
T24	routeofadministration 1938 1942	oral
T25	adversereaction 1995 2055	nausea, diarrhea, impotence, rash, flatulence, hypertension,
T26	adversereaction 2060 2068	asthenia
T27	company 2124 2148	Par Pharmaceutical, Inc.
T28	co-administereddrug 2326 2335	indinavir
T29	co-administereddrug 2381 2390	indinavir
T30	activeingredient 2438 2455	megestrol acetate
T31	tradename 2933 2939	Megace
T32	routeofadministration 2943 2947	oral
T33	co-administereddrug 3499 3508	Indinavir
T34	co-administereddrug 3513 3523	Zidovudine
T35	co-administereddrug 3528 3537	Rifabutin
T36	tradename 4286 4292	Megace
T37	routeofadministration 4296 4300	oral
T38	indication 4346 4365	anorexia, cachexia,
T39	indication 4372 4407	unexplained significant weight loss
T40	activeingredient 4547 4564	megestrol acetate
T41	indication 4569 4580	weight loss
T42	indication 4633 4644	weight loss
T43	activeingredient 4872 4889	Megestrol acetate
T44	indication 4936 4948	weight loss.
T45	tradename 5021 5027	Megace
T46	routeofadministration 5031 5035	oral
T47	dose 5050 5056	625 mg
T48	frequency 5056 5060	/day
T49	frequency 5066 5070	/day
T50	frequency 5087 5093	daily)
T51	tradename 5368 5374	Megace
T52	routeofadministration 5416 5420	oral
T53	activeingredient 5453 5470	megestrol acetate
T54	tradename 5479 5485	Megace
T55	activeingredient 5525 5542	megestrol acetate
T56	tradename 5546 5552	Megace
T57	routeofadministration 5553 5557	oral
T58	activeingredient 5589 5606	megestrol acetate
T59	routeofadministration 5607 5611	oral
T60	activeingredient 5713 5730	megestrol acetate
T61	activeingredient 6148 6165	Megestrol acetate
T62	activeingredient 6706 6723	megestrol acetate
T63	routeofadministration 6724 6728	oral
T64	activeingredient 6871 6889	megestrol acetate.
T65	activeingredient 7016 7033	megestrol acetate
T66	activeingredient 7258 7275	megestrol acetate
T67	tradename 7415 7421	Megace
T68	tradename 7952 7958	Megace
T69	activeingredient 8328 8346	megestrol acetate.
T70	tradename 9460 9466	Megace
T71	activeingredient 9471 9488	megestrol acetate
T72	routeofadministration 9489 9493	oral
T73	activeingredient 9547 9564	megestrol acetate
T74	routeofadministration 9565 9569	oral
T75	activeingredient 9791 9808	megestrol acetate
T76	routeofadministration 9809 9813	oral
T77	activeingredient 10087 10104	Megestrol Acetate
T78	adversereaction 10190 10198	Diarrhea
T79	adversereaction 10217 10226	Impotence
T80	adversereaction 10242 10246	Rash
T81	adversereaction 10262 10272	Flatulence
T82	adversereaction 10288 10300	Hypertension
T83	adversereaction 10315 10323	Asthenia
T84	adversereaction 10338 10346	Insomnia
T85	adversereaction 10361 10367	Nausea
T86	adversereaction 10382 10388	Anemia
T87	adversereaction 10423 10439	Libido Decreased
T88	adversereaction 10455 10464	Dyspepsia
T89	adversereaction 10479 10492	Hyperglycemia
T90	adversereaction 10507 10515	Headache
T91	adversereaction 10531 10535	Pain
T92	adversereaction 10550 10558	Vomiting
T93	adversereaction 10573 10582	Pneumonia
T94	adversereaction 10597 10614	Urinary Frequency
T95	activeingredient 11123 11140	megestrol acetate
T96	adversereaction 11195 11244	abdominal pain, chest pain, infection, moniliasis
T97	adversereaction 11249 11256	sarcoma
T98	adversereaction 11282 11296	cardiomyopathy
T99	adversereaction 11301 11312	palpitation
T100	adversereaction 11337 11403	c onsti pa tion, dr y mouth, hepatome ga l y, increased salivation
T101	adversereaction 11408 11423	oral moniliasis
T102	adversereaction 11494 11514	LDH increased, edema
T103	adversereaction 11519 11535	peripheral edema
T104	adversereaction 11556 11627	paresthesia, confusion, convulsion, depression, neuropathy, hypesthesia
T105	adversereaction 11632 11649	abnormal thinking
T106	adversereaction 11672 11699	dyspnea, cough, pharyngitis
T107	adversereaction 11704 11717	lung disorder
T108	adversereaction 11741 11799	alopecia, herpes, pruritus, vesiculobullous rash, sweating
T109	adversereaction 11804 11817	skin disorder
T110	adversereaction 11836 11845	amblyopia
T111	adversereaction 11867 11925	albuminuria, urinary incontinence, urinary tract infection
T112	adversereaction 11930 11943	gynecomastia.
T113	activeingredient 12013 12030	megestrol acetate
T114	routeofadministration 12031 12035	oral
T115	adversereaction 12055 12079	thromboembolic phenomena
T116	adversereaction 12090 12129	thrombophlebitis, deep vein thrombosis,
T117	adversereaction 12134 12153	pulmonary embolism;
T118	adversereaction 12158 12177	glucose intolerance
T119	co-administereddrug 12246 12255	Indinavir
T120	co-administereddrug 12308 12317	indinavir
T121	activeingredient 12321 12339	megestrol acetate,
T122	co-administereddrug 12375 12384	indinavir
T123	activeingredient 12432 12449	megestrol acetate
T124	co-administereddrug 12618 12628	Zidovudine
T125	co-administereddrug 12633 12642	Rifabutin
T126	co-administereddrug 12669 12679	zidovudine
T127	co-administereddrug 12684 12693	rifabutin
T128	activeingredient 12709 12726	megestrol acetate
T129	activeingredient 13029 13046	megestrol acetate
T130	tradename 13307 13313	Megace
T131	routeofadministration 13317 13321	oral
T132	activeingredient 13480 13497	megestrol acetate
T133	routeofadministration 13498 13502	oral
T134	indication 13534 13553	anorexia, cachexia,
T135	indication 13560 13595	unexplained significant weight loss
T136	activeingredient 14132 14149	Megestrol acetate
T137	activeingredient 14485 14502	Megestrol acetate
T138	tradename 14614 14620	Megace
T139	chemoclass 14629 14641	progesterone
T140	activeingredient 14879 14896	megestrol acetate
T141	routeofadministration 14897 14901	oral
T142	dose 14948 14955	1200 mg
T143	frequency 14955 14960	/day.
T144	adversereaction 15104 15194	diarrhea, nausea, abdominal pain, shortness of breath, cough, unsteady gait, listlessness,
T145	adversereaction 15199 15210	chest pain.
T146	tradename 15260 15266	Megace
T147	routeofadministration 15270 15274	oral
T148	activeingredient 15359 15376	Megestrol acetate
T149	tradename 15553 15559	Megace
T150	routeofadministration 15563 15567	oral
T151	activeingredient 15588 15606	megestrol acetate,
T152	chemoclass 15674 15687	progesterone.
T153	activeingredient 15688 15705	Megestrol acetate
T154	molecularweight 15926 15933	384.52.
T155	tradename 15935 15941	Megace
T156	routeofadministration 15951 15955	oral
T157	activeingredient 15988 16005	megestrol acetate
T158	tradename 16014 16020	Megace
T159	routeofadministration 16024 16028	oral
T160	inactiveingredient 16085 16092	alcohol
T161	inactiveingredient 16121 16328	artificial lime flavor, citric acid monohydrate, docusate sodium, hydroxypropyl methylcellulose (hypromellose), natural and artificial lemon flavor, purified water, sodium benzoate, sodium citrate dihydrate,
T162	inactiveingredient 16333 16341	sucrose.
T163	activeingredient 16469 16486	megestrol acetate
T164	indication 16510 16519	cachexia.
T165	activeingredient 16551 16568	megestrol acetate
T166	indication 16596 16596	
T167	indication 16601 16609	cachexia
T168	activeingredient 16841 16858	megestrol acetate
T169	dose 16883 16889	625 mg
T170	tradename 16905 16911	Megace
T171	routeofadministration 16915 16919	oral
T172	dose 16970 16976	800 mg
T173	activeingredient 16991 17008	megestrol acetate
T174	routeofadministration 17009 17013	oral
T175	tradename 17102 17108	Megace
T176	activeingredient 17248 17265	megestrol acetate
T177	dose 17305 17311	150 mg
T178	dose 17316 17322	675 mg
T179	tradename 17329 17335	Megace
T180	dose 17604 17610	625 mg
T181	tradename 17611 17617	Megace
T182	activeingredient 17707 17724	megestrol acetate
T183	activeingredient 17801 17818	megestrol acetate
T184	tradename 17989 17995	Megace
T185	activeingredient 18080 18097	megestrol acetate
T186	indication 18221 18232	weight loss
T187	routeofadministration 18282 18286	oral
T188	dose 18296 18302	800 mg
T189	frequency 18302 18306	/day
T190	activeingredient 18310 18327	megestrol acetate
T191	routeofadministration 18328 18332	oral
T192	activeingredient 18380 18397	megestrol acetate
T193	cmax 18402 18418	753 (539) ng/mL.
T194	auc 18436 18460	10476 (7788) ng x hr/mL.
T195	tmax 18483 18494	five hours.
T196	dose 18594 18600	750 mg
T197	activeingredient 18604 18621	megestrol acetate
T198	routeofadministration 18622 18626	oral
T199	cmax 18681 18696	490 (238) ng/mL
T200	auc 18701 18724	6779 (3048) hr x ng/mL,
T201	tmax 18765 18777	three hours.
T202	activeingredient 18967 18984	megestrol acetate
T203	dose 19024 19035	4 to 90 mg,
T204	activeingredient 19253 19270	Megestrol acetate
T205	eliminationhalflife 19570 19584	20 to 50 hours
T206	activeingredient 19763 19780	megestrol acetate
T207	co-administereddrug 19927 19948	indinavir, zidovudine
T208	co-administereddrug 19952 19961	rifabutin
T209	activeingredient 19989 20006	megestrol acetate
T210	co-administereddrug 20026 20036	Zidovudine
T211	co-administereddrug 20124 20134	zidovudine
T212	activeingredient 20140 20157	megestrol acetate
T213	co-administereddrug 20191 20200	Rifabutin
T214	co-administereddrug 20288 20297	rifabutin
T215	activeingredient 20303 20320	megestrol acetate
T216	co-administereddrug 20354 20363	Indinavir
T217	activeingredient 20452 20469	megestrol acetate
T218	dose 20471 20477	675 mg
T219	co-administereddrug 20495 20504	indinavir
T220	dose 20518 20525	800 mg)
T221	co-administereddrug 20630 20640	indinavir.
T222	activeingredient 20827 20844	megestrol acetate
T223	dose 20908 20918	13.3 mg/kg
T224	frequency 20918 20923	/day)
T225	activeingredient 21013 21030	megestrol acetate
T226	dose 21032 21055	0.01, 0.1 or 0.25 mg/kg
T227	frequency 21055 21060	/day)
T228	dose 21225 21247	0.01, 0.1 or 0.5 mg/kg
T229	frequency 21247 21251	/day
T230	activeingredient 21252 21270	megestrol acetate.
T231	dose 21330 21345	3.9 or 10 mg/kg
T232	frequency 21345 21349	/day
T233	activeingredient 21353 21370	megestrol acetate
T234	tradename 21536 21542	Megace
T235	routeofadministration 21546 21550	oral
T236	activeingredient 21607 21624	Megestrol acetate
T237	dose 21900 21922	16.25 and 32.50 mg/kg.
T238	dose 22054 22064	13.3 mg/kg
T239	frequency 22064 22069	/day)
T240	activeingredient 22297 22322	megestrol acetate-treated
T241	tradename 22572 22578	Megace
T242	activeingredient 22822 22839	megestrol acetate
T243	tradename 22897 22903	Megace
T244	activeingredient 22908 22925	megestrol acetate
T245	routeofadministration 22926 22930	oral
T246	activeingredient 22981 22998	megestrol acetate
T247	routeofadministration 22999 23003	oral
T248	activeingredient 23160 23177	megestrol acetate
T249	dose 23195 23210	100 mg, 400 mg,
T250	dose 23215 23221	800 mg
T251	frequency 23222 23229	per day
T252	indication 23267 23284	anorexia/cachexia
T253	indication 23289 23313	significant weight loss.
T254	dose 23699 23705	800 mg
T255	dose 23716 23722	400 mg
T256	dose 23861 23867	800 mg
T257	dose 23900 23906	400 mg
T258	dose 23930 23936	100 mg
T259	dose 24410 24416	800 mg
T260	dose 24434 24440	400 mg
T261	dose 24461 24467	100 mg
T262	dose 24658 24664	800 mg
T263	dose 24946 24952	800 mg
T264	activeingredient 25570 25587	megestrol acetate
T265	dose 25588 25594	800 mg
T266	frequency 25594 25598	/day
T267	indication 25636 25653	anorexia/cachexia
T268	indication 25658 25682	significant weight loss.
T269	dose 25947 25953	800 mg
T270	activeingredient 27436 27453	Megestrol Acetate
T271	routeofadministration 27454 27458	Oral
T272	activeingredient 27582 27600	Megestrol Acetate,
T273	tradename 28501 28507	Megace
T274	routeofadministration 28511 28515	oral
T275	routeofadministration 28565 28569	oral
T276	activeingredient 28602 28619	megestrol acetate
T277	tradename 28707 28713	Megace
T278	routeofadministration 28717 28721	oral
T279	activeingredient 29423 29441	megestrol acetate.
T280	tradename 29474 29480	Megace
T281	tradename 29580 29586	Megace
T282	tradename 29715 29721	Megace
T283	activeingredient 29775 29792	megestrol acetate
T284	tradename 29796 29802	Megace
T285	routeofadministration 29803 29807	oral
T286	activeingredient 29839 29856	megestrol acetate
T287	routeofadministration 29857 29861	oral
T288	tradename 29875 29881	Megace
T289	activeingredient 29904 29921	megestrol acetate
T290	tradename 29950 29956	Megace
T291	routeofadministration 29957 29961	oral
T292	activeingredient 29983 30000	megestrol acetate
T293	routeofadministration 30001 30005	oral
T294	company 30347 30381	PAR PHARMACEUTICAL COMPANIES, INC.
T295	u.s.patent 30431 30450	6,592,903 7,101,576
T296	tradename 30483 30489	Megace
T297	company 30519 30547	Bristol-Myers Squibb Company
T298	company 30560 30584	Par Pharmaceutical, Inc.
